相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer: pooled analysis of two randomized trials, the GERCOR/GISCAD intergroup study and a German multicenter study
V. Heinemann et al.
ANNALS OF ONCOLOGY (2007)
Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer:: A randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group
Richard Herrmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Malcolm J. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy
A. Sultana et al.
BRITISH JOURNAL OF CANCER (2007)
Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer
Volker Heinemann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer
H Oettle et al.
ANNALS OF ONCOLOGY (2005)
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer:: Results of a GERCOR and GISCAD phase III trial
C Louvet et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer
E Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Outcome of flat bone sarcomas (other than Ewing's) in children and adolescents: a study of 25 cases
V Minard-Colin et al.
BRITISH JOURNAL OF CANCER (2004)
Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate
CMR Lima et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Phase II study of gemcitabine in combination with docetaxel in patients with advanced pancreatic carcinoma (E1298) - A trial of the Eastern Cooperative Oncology Group
RC Shepard et al.
ONCOLOGY (2004)
Randomized phase II comparison of dose-intense gemcitabine: Thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma
M Tempero et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: A phase III trial of the National Cancer Institute of Canada Clinical Trials Group
MJ Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study
SR Alberts et al.
ANNALS OF ONCOLOGY (2003)
Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma
SJ Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Weekly gemcitabine and cisplatin chemotherapy:: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients.: A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
S Cascinu et al.
ANNALS OF ONCOLOGY (2003)
Newer approaches to gemcitabine-based therapy of pancreatic cancer: Fixed-dose-rate infusion and novel agents
HS Hochster
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297
JD Berlin et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer
SR Bramhall et al.
BRITISH JOURNAL OF CANCER (2002)
Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma:: Final results of a GERCOR multicenter phase II study
C Louvet et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Phase II study of oral capecitabine in patients with advanced or metastatic pancreatic cancer
TH Cartwright et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
A phase II trial of marimastat in advanced pancreatic cancer
JD Evans et al.
BRITISH JOURNAL OF CANCER (2001)
Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer
V Heinemann et al.
ANNALS OF ONCOLOGY (2000)
Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer
T Brodowicz et al.
ANTI-CANCER DRUGS (2000)
分享论文
